Prot# MFG4809g: An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S in Patients with Relapsed or Refractory t(4;14)-Positive Multiple Myeloma

Project: Research project

Status	Finished
Effective start/end date	7/27/10 → 7/27/13

Project Details